Macroangiopathy in adults and children with diabetes: From molecular mechanisms to vascular damage (part 1)

被引:14
作者
Di Marzio, D.
Mohn, A.
Mokini, Z. H.
Giannini, C.
Chiarelli, F.
机构
[1] Univ G dAnnunzio, Dept Pediat, I-66100 Chieti, Italy
[2] Univ Florence, Anna Meyer Childrens Hosp, Dept Pediat, Florence, Italy
关键词
diabetes mellitus; hyperglycemia; atherosclerosis; TNF-alpha; macrophages; smooth muscle cells; lipids; macroangiopathy; nitric oxide;
D O I
10.1055/s-2006-955081
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus (T2DM) is an increasing problem in childhood; however type 1 diabetes mellitus (T1DM) remains by far the most common type of diabetes in this age group. In this review we will focus on T1DM, because this will have the greatest implication for patients diagnosed in childhood. During the atherosclerotic process, several molecular, receptorial and cellular factors provide a continous mechanism of vascular damage. in diabetic children this state seems to be enhanced and facilitated so that accelerated atherosclerosis is associated with an increased risk of cardiovascular events in respect to the non diabetic population. Hyperglycemia per se and associated with diabetes is an important risk factor for atherosclerosis. At present a substantial part of children with diabetes do not reach satisfactory glycemic control. Other risk factors for the development and progression of atherosclerosis may be inherited or develop in the course of the disease: hypertension, dyslipidemia, insulin resistance, obesity, cigarette smoking, physical inactivity, disturbance of platelet function, coagulation and fibrinolysis. The development and progression of atherosclerosis should be blocked at an early age, if possible. Primary prevention to all risk factors for cardiovascular disease is important and intervention is indicated if necessary. At the moment the best therapeutic strategy is to maintain metabolic control at a physiologic level and perform screening and early intervention for vascular complications.
引用
收藏
页码:691 / 705
页数:15
相关论文
共 181 条
[1]   Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1 [J].
Accad, M ;
Smith, SJ ;
Newland, DL ;
Sanan, DA ;
King, LE ;
Linton, MF ;
Fazio, S ;
Farese, RV .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (06) :711-719
[2]   Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways [J].
Alikhani, ZB ;
Alikhani, M ;
Boyd, CM ;
Nagao, K ;
Trackman, PC ;
Graves, DT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (13) :12087-12095
[3]   Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes [J].
Aronson, D .
JOURNAL OF HYPERTENSION, 2003, 21 (01) :3-12
[4]   Regulation of protein kinase C by short term hyperglycaemia in human platelets in vivo and in vitro [J].
Assert, R ;
Scherk, G ;
Bumbure, A ;
Pirags, V ;
Schatz, H ;
Pfeiffer, AFH .
DIABETOLOGIA, 2001, 44 (02) :188-195
[5]   HYPOTHESIS - VASA VASORUM AND NEOVASCULARIZATION OF HUMAN CORONARY-ARTERIES - A POSSIBLE ROLE IN THE PATHO-PHYSIOLOGY OF ATHEROSCLEROSIS [J].
BARGER, AC ;
BEEUWKES, R ;
LAINEY, LL ;
SILVERMAN, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (03) :175-177
[6]   ATHEROSCLEROSIS OF THE AORTA AND CORONARY-ARTERIES AND CARDIOVASCULAR RISK-FACTORS IN PERSONS AGED 6 TO 30 YEARS AND STUDIED AT NECROPSY (THE BOGALUSA HEART-STUDY) [J].
BERENSON, GS ;
WATTIGNEY, WA ;
TRACY, RE ;
NEWMAN, WP ;
SRINIVASAN, SR ;
WEBBER, LS ;
DALFERES, ER ;
STRONG, JP .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (09) :851-858
[7]   Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM [J].
Berg, TJ ;
DahlJorgensen, K ;
Torjesen, PA ;
Hanssen, KF .
DIABETES CARE, 1997, 20 (06) :1006-1008
[8]   Understanding RAGE, the receptor for advanced glycation end products [J].
Bierhaus, A ;
Humpert, PM ;
Morcos, M ;
Wendt, T ;
Chavakis, T ;
Arnold, B ;
Stern, DM ;
Nawroth, PP .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2005, 83 (11) :876-886
[9]   Innate and acquired immunity in atherogenesis [J].
Binder, CJ ;
Chang, MK ;
Shaw, PX ;
Miller, YI ;
Hartvigsen, K ;
Dewan, A ;
Witztum, JL .
NATURE MEDICINE, 2002, 8 (11) :1218-1226
[10]   Interleukin-8 and its receptor CXCR2 in atherosclerosis [J].
Boisvert, WA ;
Curtiss, LK ;
Terkeltaub, RA .
IMMUNOLOGIC RESEARCH, 2000, 21 (2-3) :129-137